Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

WuXi Healthcare Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 40
Average round size
info
The average size of a deal this fund participated in
$40M
Portfolio companies 26
Rounds per year 3.08
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.35
Exits 8
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
Summary

The main department of described VC is located in the Cambridge. The fund was located in North America if to be more exact in United States.

The important activity for fund was in 2016. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this WuXi Healthcare Ventures works on 15 percentage points less the average amount of lead investments. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. When the investment is from WuXi Healthcare Ventures the average startup value is 500 millions - 1 billion dollars. The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.

The overall number of key employees were 2.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Medical, Genetics. Among the most popular portfolio startups of the fund, we may highlight 23andMe, CStone Pharmaceuticals, Hua Medicine. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the WuXi Healthcare Ventures, startups are often financed by ARCH Venture Partners, Avalon Ventures, Torrey Pines Investment. The meaningful sponsors for the fund in investment in the same round are F-Prime Capital, ARCH Venture Partners, Canaan Partners. In the next rounds fund is usually obtained by Venrock, ARCH Venture Partners, 6 Dimensions Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of WuXi Healthcare Ventures:
Typical Co-investors
WuXi Healthcare Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after WuXi Healthcare Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avataar Venture Partners Bangalore, India, Karnataka
Black Coral Capital Boston, Massachusetts, United States
Blackbird Ventures -
Canyon Creek Capital California, Santa Monica, United States
Franchise India Holdings Limited Delhi, India, New Delhi
Georgian Co-Investment Fund Georgia, Tbilisi, Tbilisi
Gilde Healthcare The Netherlands, Utrecht, Utrecht
Global Frontier Partners Bangalore, India, Karnataka
Guloien Capital -
Hangzhou Binjiang Real Estate Group China, Hangzhou, Zhejiang
HIX Capital Brazil, São Paulo, Sao Paulo
Huidaya Investment Management China, Hubei, Wuhan
Kearny Bank -
MarathonArtists LABs England, London, United Kingdom
New York Ventures New York, New York, United States
QuaeroQ -
SODECI Abidjan, Côte d'Ivoire, Lagunes
Stirling Square Capital Partners Kersey, Lancashire, United Kingdom
Sunwoda Electronic China, Guangdong, Shenzhen
Susquehanna Lititz, Pennsylvania, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
23 Mar 2021 -

LifeMine Therapeutics

Biotechnology
Life Science
Therapeutics
$50M07 Jan 2021 Cambridge, Massachusetts, United States

Halda Therapeutics

$25M13 Nov 2020 Branford, Connecticut, United States

XW Laboratories

Biotechnology
Health Care
Pharmaceutical
$40M18 Sep 2020 Jiang'an District, Hubei, China

Antengene Corporation

Biopharma
Biotechnology
Life Science
Pharmaceutical
$120M02 Jan 2019 Shanghai, China

Refuge Biotechnologies

Biotechnology
Genetics
Health Care
Therapeutics
$25M02 May 2018 California, United States

UNITY Biotechnology

Biotechnology
Health Care
Medical
$55M19 Mar 2018 California, United States

IDEAYA Biosciences

Biotechnology
Health Care
Therapeutics
$94M15 Mar 2018 South San Francisco, California, United States

Medeor Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$57M27 Nov 2017 South San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent WuXi Healthcare Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 40
Average round size 40M
Rounds per year 3.08
Peak activity year 2016
Lead investments 3
Follow on index 0.35
Exits 8
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Zenas BioPharma

Biopharma
Health Care
Pharmaceutical
23 Mar 2021 -

LifeMine Therapeutics

Biotechnology
Life Science
Therapeutics
$50M07 Jan 2021 Cambridge, Massachusetts, United States

Halda Therapeutics

$25M13 Nov 2020 Branford, Connecticut, United States

XW Laboratories

Biotechnology
Health Care
Pharmaceutical
$40M18 Sep 2020 Jiang'an District, Hubei, China

Antengene Corporation

Biopharma
Biotechnology
Life Science
Pharmaceutical
$120M02 Jan 2019 Shanghai, China

Refuge Biotechnologies

Biotechnology
Genetics
Health Care
Therapeutics
$25M02 May 2018 California, United States

UNITY Biotechnology

Biotechnology
Health Care
Medical
$55M19 Mar 2018 California, United States

IDEAYA Biosciences

Biotechnology
Health Care
Therapeutics
$94M15 Mar 2018 South San Francisco, California, United States

Medeor Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$57M27 Nov 2017 South San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: